Groupe Athena Inc (GATA) 0.2325 $GATA
Groupe Athena, Inc. Issues Revenue Guidance
ACCESSWIRE - Tue Sep 02, 8:19AM CDT
MUMBAI, INDIA / ACCESSWIRE / September 2, 2014 / Groupe Athena, Inc. (OTC PINK: GATA), (PINKSHEETS: GATA), announced today that based on current orders in hand they anticipate a strong first quarter and project total revenue for the period could top $20 million for the first time.
Groupe Athena, Inc. Posts Year End Financials, Betters Previous Record by 15%, Marks 5th Consecutive Double Digit Gain in Annual Revenue
ACCESSWIRE - Mon Jul 28, 3:24PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 28, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) has posted the results for their fiscal year ending June 30, 2014. Annual revenue for the period was $65,189,762 which is an increase of more than 15% over the previous record fiscal year and represents an amazing 5th consecutive double digit increase in annual revenue. EBITDA for the year was also a record $10,938,698 and net after tax income for the period was $6,501,645 or $.14 per share.
Groupe Athena, Inc Sets Release Date for Year End Financials Release, Reiterates Revenue Guidance
ACCESSWIRE - Mon Jul 21, 3:20PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 21, 2014 / Groupe Athena, Inc. (OTC: Pink sheets GATA) announced today they will release their financial results for the fiscal year ended June 30, 2014 after the close of the market on July 28.
Groupe Athena, Inc. in Final Discussions for Drug Manufacture, Sets Release Date for 3rd Quarter Financials
Marketwire - Tue Mar 25, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA) announced today they are in the final stages of negotiations with 2 Indian pharmaceutical companies for the manufacture of the drug Atorvastatin, the generic form of Lipitor. The company expects to finalize terms by the end of April with formal license application to the UK MHRA expected to follow by mid year.
Groupe Athena, Inc. Provides Guidance on Current Orders
Marketwire - Tue Mar 11, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink: GATA) made the following announcement:
UPDATE: Groupe Athena, Inc. Continues Pace for Record Fiscal Year With Strong Second Quarter Sales
Marketwire - Mon Mar 10, 1:45PM CDT
Groupe Athena, Inc. (OTC Pink: GATA) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.
Auxilium Pharmaceuticals, Inc. To Present At The Barclay's Global Healthcare Conference
PR Newswire - Tue Mar 04, 5:30AM CST
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Barclay's Global Healthcare Conference to be held March 11-13, 2014 at the Loews Hotel in Miami. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 3:45 p.m. ET on Tuesday, March 11, 2014.
Groupe Athena, Inc. Continues Pace for Record Fiscal Year With Strong Second Quarter Sales
Marketwire - Mon Feb 10, 3:30PM CST
Groupe Athena, Inc. (OTC Pink: GATA) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.
OtcbbJournal.com, Providing Savvy Traders With Their Micro-Cap Stock Research
Marketwire - Tue Sep 10, 9:28AM CDT
Telecorp, Inc. (PINKSHEETS: TLNUF) has created and is in the final stages of completing a suite of web-based software that is customized for integration into professional work environments. This technology allows any user to maximize their individual efforts, team focus and management agendas to reduce cost, increase sales, monitor the analytics, and streamline the entire operation. Get a full company report on TLNUF at the following link: http://bit.ly/REPORT-TLNUF
Groupe Athena, Inc. Welcomes New Director, Announces Intent to Apply for UK License
Business Wire - Thu Sep 05, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink:GATA.PK) announced today that Dr. Chitra Saxena has been elected to join their Board of Directors. Dr. Saxena is a skilled expert in UK and European regulatory requirements for prescription and non-prescription pharmaceutical drugs. During her distinguished career, she has been associated with several multinational companies including Reckitt Benckiser, Slough, UK, Bayer PLC, Newbury, UK and DDSA Pharmaceuticals Limited, Fulham, UK. She has also published 23 research papers in various internationally reputed trade journals.
Groupe Athena Inc. Releases Year End Financials, Continues Record Revenue and Earnings Growth
ACCESSWIRE - Mon Aug 05, 3:20PM CDT
Mumbai, India, August 5, 2013 - Groupe Athena, Inc. (OTCPink: GATA) is very excited to post the results for their fiscal year ending June 30, 2013. Annual revenue for the period was $56,457,443 which is an increase of more than 26% over the previous fiscal year and represents another new benchmark for the company. EBITDA for the year was also strong at $8,956,726 and net after tax income for the period was $5,440,694 or $.12 per share.
Groupe Athena, Inc. Issues Revenue Guidance
ACCESSWIRE - Tue Sep 02, 8:19AM CDT
MUMBAI, INDIA / ACCESSWIRE / September 2, 2014 / Groupe Athena, Inc. (OTC PINK: GATA), (PINKSHEETS: GATA), announced today that based on current orders in hand they anticipate a strong first quarter and project total revenue for the period could top $20 million for the first time.
Groupe Athena, Inc. Posts Year End Financials, Betters Previous Record by 15%, Marks 5th Consecutive Double Digit Gain in Annual Revenue
ACCESSWIRE - Mon Jul 28, 3:24PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 28, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) has posted the results for their fiscal year ending June 30, 2014. Annual revenue for the period was $65,189,762 which is an increase of more than 15% over the previous record fiscal year and represents an amazing 5th consecutive double digit increase in annual revenue. EBITDA for the year was also a record $10,938,698 and net after tax income for the period was $6,501,645 or $.14 per share.
Groupe Athena, Inc Sets Release Date for Year End Financials Release, Reiterates Revenue Guidance
ACCESSWIRE - Mon Jul 21, 3:20PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 21, 2014 / Groupe Athena, Inc. (OTC: Pink sheets GATA) announced today they will release their financial results for the fiscal year ended June 30, 2014 after the close of the market on July 28.
Groupe Athena, Inc. in Final Discussions for Drug Manufacture, Sets Release Date for 3rd Quarter Financials
Marketwire - Tue Mar 25, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA) announced today they are in the final stages of negotiations with 2 Indian pharmaceutical companies for the manufacture of the drug Atorvastatin, the generic form of Lipitor. The company expects to finalize terms by the end of April with formal license application to the UK MHRA expected to follow by mid year.
Groupe Athena, Inc. Provides Guidance on Current Orders
Marketwire - Tue Mar 11, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink: GATA) made the following announcement:
UPDATE: Groupe Athena, Inc. Continues Pace for Record Fiscal Year With Strong Second Quarter Sales
Marketwire - Mon Mar 10, 1:45PM CDT
Groupe Athena, Inc. (OTC Pink: GATA) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.
Auxilium Pharmaceuticals, Inc. To Present At The Barclay's Global Healthcare Conference
PR Newswire - Tue Mar 04, 5:30AM CST
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Barclay's Global Healthcare Conference to be held March 11-13, 2014 at the Loews Hotel in Miami. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 3:45 p.m. ET on Tuesday, March 11, 2014.
Groupe Athena, Inc. Continues Pace for Record Fiscal Year With Strong Second Quarter Sales
Marketwire - Mon Feb 10, 3:30PM CST
Groupe Athena, Inc. (OTC Pink: GATA) today posted their quarterly results for the three months ending December 31, 2013. The company reported revenues of $17,961,452 which is an increase of 21% when compared to the corresponding period in 2012 and represents the strongest 6 month earnings period in the company's history. Operating income for the quarter was also strong at $3, 097,791, an increase of over 26% from $2.45 million for the same period in 2012.
OtcbbJournal.com, Providing Savvy Traders With Their Micro-Cap Stock Research
Marketwire - Tue Sep 10, 9:28AM CDT
Telecorp, Inc. (PINKSHEETS: TLNUF) has created and is in the final stages of completing a suite of web-based software that is customized for integration into professional work environments. This technology allows any user to maximize their individual efforts, team focus and management agendas to reduce cost, increase sales, monitor the analytics, and streamline the entire operation. Get a full company report on TLNUF at the following link: http://bit.ly/REPORT-TLNUF
Groupe Athena, Inc. Welcomes New Director, Announces Intent to Apply for UK License
Business Wire - Thu Sep 05, 8:15AM CDT
Groupe Athena, Inc. (OTC Pink:GATA.PK) announced today that Dr. Chitra Saxena has been elected to join their Board of Directors. Dr. Saxena is a skilled expert in UK and European regulatory requirements for prescription and non-prescription pharmaceutical drugs. During her distinguished career, she has been associated with several multinational companies including Reckitt Benckiser, Slough, UK, Bayer PLC, Newbury, UK and DDSA Pharmaceuticals Limited, Fulham, UK. She has also published 23 research papers in various internationally reputed trade journals.
Groupe Athena Inc. Releases Year End Financials, Continues Record Revenue and Earnings Growth
ACCESSWIRE - Mon Aug 05, 3:20PM CDT
Mumbai, India, August 5, 2013 - Groupe Athena, Inc. (OTCPink: GATA) is very excited to post the results for their fiscal year ending June 30, 2013. Annual revenue for the period was $56,457,443 which is an increase of more than 26% over the previous fiscal year and represents another new benchmark for the company. EBITDA for the year was also strong at $8,956,726 and net after tax income for the period was $5,440,694 or $.12 per share.
